Grants for Independent School Districts

This notice of funding opportuntity (NOFO) encourages applications for investigator-initiated multi site clinical trials (e.g., efficacy, effectiveness, or pragmatic trials) to study the effects of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions), and/or multicomponent interventions that include physical, psychological, and/or nutritional approaches in NCCIH- designated areas of high research priority. Clinical Coordinating Centers (CCC) should develop and implement the proposed fully powered multi-site clinical trial (Phase III and beyond). The objective of a CCC application is to present the scientific rationale and a comprehensive scientific and operational plan for the clinical trial. CCCapplications are expected to describe plans for project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. CCC applications submitted under this NOFO will utilize a two-phase, milestone-driven cooperative agreement (UG3/UH3) funding mechanism. In addition, an accompanying Data Coordinating Center (DCC) application (U24), submitted under PAR-24-087 proposing a data analysis and data management plan for the clinical project is required. Both a CCC application and a corresponding DCC application need to be submitted simultaneously for consideration by NCCIH. For additional information about the mission, strategic vision, and research priorities of NCCIH, applicants are encouraged to consult the NCCIH website: (https://nccih.nih.gov/about/plans). Applicants are encouraged to contact the appropriate Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this NOFO.

This funding opportunity supports researchers conducting multi-site clinical trials to evaluate complementary and integrative health approaches that combine physical and psychological therapies, aiming to gather essential data for future larger-scale studies.

HIV infection and substance use are comorbid conditions that bidirectionally and synergistically influence the deleterious outcomes in people who suffer from substance use disorders (SUD). The persistence and transcriptional reactivation of HIV lead to the development of neuropathological complications. Strategies to address viral latency include silencing of HIV transcription and reactivation and clearance. The goal of this initiative is to support research aimed at (1) identification of targets and pathways by which transcriptional activity of HIV can be suppressed in HIV reservoirs including the CNS in people with SUD, and (2) application of emerging small molecule drug discovery approaches to identify novel compounds that can be utilized as pharmacological probes and as drugs to suppress HIV transcription in people with HIV-SUD comorbidity.

This notice of funding opportunity (NOFO), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an investigator-initiated multi site clinical trial (Phase III and beyond) application submitted under companion PAR-21-243. The DCC application must be specific to the companion Clinical Coordinating Center (CCC) application. The objective of the DCC application is to propose a comprehensive plan that provides overall project coordination, and administrative, data management, and biostatistical support for the proposed clinical trial. Both a DCC application and a corresponding CCC application need to be submitted simultaneously for consideration by NCCIH. Trials for which this NOFO applies must be relevant to the research mission of NCCIH and considered a high priority by the Center. For additional information about the mission, strategic vision, and research priorities of NCCIH, applicants are encouraged to consult the NCCIH website (http://www.nccih.nih.gov). Applicants are encouraged to contact the appropriate Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this NOFO. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

This funding opportunity supports U.S. educational institutions in developing programs that train a diverse workforce in research related to diabetes, digestive diseases, and kidney health, through skills courses and research experiences.

The purpose of this funding opportunity is to support the development of Clinical Outcome Assessments (COA) for Substance Use Disorders (SUD). The COA development plan is expected to progress into the FDA drug development tool qualification program. This notice of funding opportunity (NOFO) utilizes the UG3/UH3Phased Innovation Awards Cooperative Agreement grant mechanism that includes two phases. The applications responding to this NOFO should contain a COA development plan that will cover both UG3 and UH3 phases. In the first 2-year UG3 phasethe project must have a set of operational milestones to be completed by the end of this period. Once NIDA program has evaluated the progress of the UG3 phase and determined that the UG3 phase has been successfully completed, it transitions to the UH3 phase to be funded for three additional years.The goal of this NOFO is to expand the armamentarium of COA that are FDA qualified as drug development tool (DDT) in the context of use (COI) of a SUD. Achieving this goal will greatly facilitate the development of treatments for SUDs. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

This funding opportunity supports the development of innovative informatics tools to improve cancer research and management, targeting researchers and institutions focused on enhancing data handling and analysis in the field of oncology.

This funding opportunity supports the development of innovative informatics technologies to improve cancer research and management, targeting researchers and organizations focused on cancer biology, treatment, prevention, and health disparities.

This funding opportunity provides support for the ongoing development and maintenance of valuable informatics tools and resources that enhance cancer research and management, benefiting researchers and the broader cancer community.

This funding opportunity supports researchers in developing innovative informatics methods and algorithms to improve cancer research and management across various areas, including diagnosis, treatment, and prevention.

The purpose of this Notice of Funding Opportunity (NOFO) is to support the development and validation of reagents/tools to support research to characterize cellular and molecular constituents of the bat immune system and for the study of protective innate and adaptive immune mechanisms in bats. The Research Resource Program established by this NOFO will participate within a collaborative research network to advance understanding of the bat immune response. This NOFO will support the establishment and operation of a Bat Immunology Research Resource Program for the development and validation of reagents/tools for use in immunological studies using the bat model system. The recipient will participate in the Bat Immunology Network, which will consist of the Research Resource Program, the research projects supported by RFA-AI-23-068, and possible other participants as determined by NIAID. The Research Resource Program will conduct reagent/tool development and validation using appropriate systems, which includes testing against multiple bat species. While other members of the Bat Immunology Network may assist in validation efforts, reagent/tool validation is the responsibility of the Research Resource Program. Reagents/tools developed by the Research Resource Program will be provided to the research projects of the Bat Immunology Network. Reagents/tools will be made available to the broader research community through technology transfer arrangements, deposition to nonprofit repositories, and/or timely transfer to industry for commercialization. Areas of high priority include, but are not limited to, the development and validation of the following: Soluble immune molecules (e.g., cytokines, chemokines) for use in tissue culture or in vivo animal studies Antibodies or other probes/detection markers for use in cellular phenotyping, functional studies and/or immunoassays

The purpose of this Notice of Funding Opportunity (NOFO) is to support research to characterize cellular and molecular constituents of the bat immune system and to understand protective innate and adaptive immune mechanisms in bats. Research projects supported by this NOFO will form a collaborative research network to advance understanding of the bat immune response. This NOFO will support research projects to characterize the bat immune system, including defining protective innate or adaptive immune molecules and mechanisms. As little is known about the bat immune system, projects may be descriptive in nature or may be supported by limited preliminary data. Projects should emphasize the strength of the conceptual framework and the potential of the project to advance understanding of the bat immune system. Projects may propose the development of critical reagents for the project, though those development and validation activities may be transferred to the Research Resource Program after award. Research areas of high priority include, but are not limited to, the following: Characterization of the cellular constituents of the bat immune system Dissection of the molecules and pathways involved in the regulation of the bat innate and/or adaptive immune system Mechanistic studies of bat immunity, including intrinsic immunity and regulation of inflammation Studies on the quality, magnitude, and kinetics of bat immune responses during pathogenic infection and after pathogen clearance Role of metabolism or other intrinsic factors in bat immune regulation Structural studies of bat immune proteins

This funding opportunity supports researchers in developing small molecule chemical probes to investigate biological processes related to mental health, aging, drug addiction, and eye diseases.

This grant provides financial support to educators in the School District of the Menomonie Area for projects that enhance learning and academic achievement, particularly in history, culture, and the arts.

The Women's Giving Circle Grant Fund is a competitive grant opportunity offered annually by the Women's Giving Circle (WGC) of Dunn County. The WGC aims to support the needs of women and families in Dunn County through collaborative philanthropy. Non-profit organizations that primarily benefit women and/or children/families are eligible to apply. The typical award amounts range from $500 to $2,500 or more. Applicants must be certified 501(c)(3) organizations or governmental/educational organizations. The proposed project must have a geographical focus on Dunn County and demonstrate cultural sensitivity. The grant does not fund capital campaigns, deficit reductions, organizational endowments, travel grants, event tickets/sponsorships, ongoing operational expenses, grants to individuals, political parties/activities/candidates/action committees, or programs requiring adherence to religious beliefs. Only one grant proposal per organization is allowed per cycle, and all funds must be used within one year unless an extension is granted. The decision process involves review by the grants committee and final approval by the WGC board members in July. Notification of decisions will be sent in August, and the grant funds must be used within one calendar year. Grantees are required to acknowledge support from the Women's Giving Circle in their project materials and submit a final grant report within 30 days of project completion or one year from the award date. To apply for this grant opportunity, eligible applicants must create an account on the Community Foundation's online grant application system starting in January 2022. Required uploads include current Board of Directors information, organizational budget with projected revenues/expenses for the current year, audited financial statement (if available), and proof of current IRS 990 filing. For more information or assistance with the application process, applicants can contact the Community Foundation at 715-232-8019 or email grants@cfdunncounty.org. Funding Organization: Women's Giving Circle (WGC) of Dunn County Contact Information: Community Foundation of Dunn County, 715-232-8019, grants@cfdunncounty.org Award Details: Typical award amounts range from $500 to $2,500 or more. Eligibility: Non-profit organizations that primarily benefit women and/or children/families. Applicants

The School Construction Assistance Program (SCAP) provides funding assistance to school districts that are undertaking a major new construction or modernization project. Projects must meet eligibility requirements. School districts are responsible to secure local funding for construction projects. If eligible, the State provides partial funding based on formulas, allowances, and costs related to certain aspects of a construction project called recognized project cost. The enrollment projection methodology excludes the number of students residing outside the school district who are enrolled in alternative learning experience (ALE) programs under RCW 28A.232.010. The current Student Enrollment Cohort Projections - Report 1049 are available in ICOS.

The purpose of the funding opportunity is to expand and advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on potential risks from skin lightening products containing hydroquinone and/or mercury.Applicants will research and propose innovative and community-based strategies and activities that have the potential to strengthen the science base for education and public health awareness on the use of and potential risks from over-the-counter (OTC) skin lightening products.

This funding opportunity supports research that explores the effects of aging on individuals living with HIV, focusing on improving health outcomes and management strategies for this population.

This funding opportunity supports nonprofits, government units, and educational institutions that address community needs in Beaver Island, Boyne City, Charlevoix, and East Jordan, Michigan.

The purpose of this funding opportunity announcement (FOA) is to support efficient natural history studies alone or in conjunction with the development and validation of clinical outcome assessments (COAs) and/or biomarker studies to address the unmet needs in rare neurodegenerative diseases for children and adults. Through the support of studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare neurodegenerative disease or multiple rare neurodegenerative diseases with similar pathophysiology, and facilitate rare disease product development.